发明名称 |
DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING |
摘要 |
Dry powder formulations for inhalation and their use in the treatment diseases and conditions. The formulation contains a uniform blend of a first spray-dried powder and a second spray-dried powder. The first spray-dried powder contains spray-dried particles of a therapeutically active ingredient dispersed in a pharmaceutically acceptable hydrophobic excipient. The second spray-dried powder contains spray-dried particles formed from a pharmaceutically acceptable hydrophobic excipient but are substantially free of any therapeutically active ingredient. The active ingredient in the first spray-dried powder is loaded sufficiently high to compensate for the second spray-dried powder being substantially free of any active ingredient. A process for preparing such formulations is also described. |
申请公布号 |
US2015374623(A1) |
申请公布日期 |
2015.12.31 |
申请号 |
US201414768257 |
申请日期 |
2014.03.11 |
申请人 |
NOVARTIS AG |
发明人 |
Weers Jeffry;Huang Daniel;Tarara Thomas E.;Miller Danforth |
分类号 |
A61K9/00;A61M15/00;A61K31/40;A61K9/16;A61K31/4704;A61K31/58 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A powder formulation for inhalation, comprising a substantially uniform blend of a first engineered powder and a second engineered powder,
said first engineered powder comprising first spray-dried particles comprising a crystalline therapeutically active ingredient dispersed in a pharmaceutically acceptable hydrophobic excipient; said second engineered powder comprising second spray-dried particles of a pharmaceutically acceptable hydrophobic excipient, wherein the second spray-dried particles are substantially free of any therapeutically active ingredient; and wherein a loading of the active ingredient in said first engineered powder is sufficiently high to achieve a desired target dose of the active ingredient. |
地址 |
Basel CH |